Clinically validated, convenient and easy to useView our products
Would you like to learn more about our products? Request any information you wish to receive here.
Groningen, the Netherlands, April 15, 2016 Diagnoptics wird vom 04.05. – 06.05.16 von 09:30 bis 17:30 Uhr in Berlin bei dem DDG Kongress teilneh......» read more
The AGE Reader and Diab-spot have received approval in a number of countries. Please check with the distributor in your country or Diagnoptics what the regulatory approval status is in your country. US Caution: Federal law restricts the AGE Reader and Diab-spot system to investigational use only. Commercial distribution has not been granted by the US FDA. Please see the AGE Reader and Diab-spot user manuals for descriptions of all relevant warnings, cautions, contraindications and safety information.